Figure 1From: Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetesProportion of patients who achieved clinically relevant changes in FBG (4.1–5.5 mmol/l), 2 h PBG (7.2–8.9 mmol/l), or HbA1c (< 7.0%) target at week 20. * P < 0.001 vs. baseline.Back to article page